Ross Muken sold $4K of SOPHiA GENETICS stock
By AlphaYouPublished Form 4
Muken Ross
Reporting filer
Ross Muken reported selling 422 shares of SOPHiA GENETICS SA for about $4K ($8.33 a share on average). Form 4 filed Sep 22, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Sep 22, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Muken Ross | 2026-09-21 | S | Sale | 422 | 8.33 | 670,229 | 1 day | Filed terms
|
Ordinary Shares
- Owner
- Muken Ross
- Date
- 2026-09-21
- Code
- S
- Action
- Sale
- Quantity
- 422
- Price
- 8.33
- Following holdings
- 670,229
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Ordinary Shares
- transaction Date: 2026-09-21
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 422
- id: F1
- transaction Price Per Share: 8.33
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 670229
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Muken Ross: Chief Executive Officer, Director.
- The filing reports a Rule 10b5-1 trading plan.
- F1: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on September 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
Original sources
Prepared automatically from public filing data. Report a correction.